COVID-19 and Down-Round Financings

By Jeremy Glaser, Sebastian Lucier & Sebastian A. Bacon

Although no one can predict the long-term economic impact of COVID-19, early indications show similarities to the last significant economic downturn that started in 2008. During that period, venture capital investment decreased significantly both domestically and abroad — in the first quarter of 2009, alone, there were double-digit declines in venture financings. The decrease in available capital during that time period led to a significant uptick in financing rounds at lower valuations than in previous rounds, or so-called “down-round financings.” Companies should be prepared for a similar occurrence, and be ready to take precautionary steps in order to minimize risks relating to a down-round financing.

A Down Round

If a company will need capital in the near future, it should be continuously searching for capital sources long before that need becomes dire. If after careful consideration a company believes that a down-round financing is the best (or only) available option to obtain necessary funding, it should be aware that the lower valuation and frequently onerous terms of a down-round financing — which can include tranched payments based on company milestones, pay-to-play provisions, forced conversion of non-participating current investors from preferred stock to common stock and loss of important rights by non-participating investors — could cause existing stockholders to engage in litigation. Generally, such claims will center on a breach of a fiduciary duty by the company’s directors, particularly when the down-round financing is led by existing stockholders of the company that have the ability to block other transactions or influence the board deliberations.

Fiduciary Duties

The vast majority of venture-backed companies are Delaware corporations, and under Delaware law, each director owes fiduciary duties of good faith, care and loyalty to the corporation and its stockholders. With respect to the fiduciary duty owed to stockholders, the Delaware courts made it clear in the Trados case that the fiduciary duty is owed to the common stockholders, not the preferred stockholders. In a down-round financing led by existing stockholders, a transaction approved by the majority of the disinterested directors or, where there is no controlling stockholder, a majority of the disinterested and informed stockholders, will receive the benefit of the business judgment rule, which directs a court to show deference to the decisions of the company and assume that the directors acted in accordance with their fiduciary duties. Where the business judgment rule applies, the burden to prove a breach of fiduciary duties is on the plaintiff. In contrast, where the business judgment rule does not apply, the Delaware courts will apply the onerous entire fairness standard of review, which places the burden on the defendant company to prove that the price and course of dealing between the parties were fair, a much more burdensome, onerous and ultimately expensive proposition for a company.

Further Precautionary Steps

Obtaining the approval of disinterested directors or the disinterested and informed stockholders is highly desirable, but Delaware courts have complicated the process by broadly construing the concept of a conflict of interest for directors and stockholders in financing transactions and have found a conflict of interest even when a director or stockholder is not affiliated with an investor. As such, it can be prudent to take further steps beyond obtaining such approval in order to minimize the litigation risk. One such step is for a company to appoint a special committee of the board comprised entirely of disinterested directors to make an independent determination with respect to the financing, which is good procedure and creates a good corporate record. A special committee is especially prudent in a case where existing investors, particularly those participating in the financing, hold a majority of the board seats or otherwise have the ability to block or influence a board decision.

In addition, a company should obtain the approval of as many of the directors or stockholders it believes to be disinterested as possible to protect against a subsequent determination by a court that certain of the directors or stockholders are not disinterested.

Another way to limit the risk of litigation in a down-round financing is by conducting a rights offering, whereby all current investors in a company are allowed to participate on a pro rata basis at the same price and on the same terms as the investors proposing the down-round financing. This mitigates the argument that the existing stockholders were unfairly diluted by an incorrectly priced financing because they have the opportunity to participate in the financing and benefit from the depressed valuation. However, rights offerings are imperfect solutions because not all existing investors will have the liquidity to be able to participate in the financing, and most rights offerings are limited to accredited investors to avoid securities law complications. Moreover, in a recent unpublished bench ruling, the Delaware Chancery Court found that a rights offering does not necessarily preclude all claims for breach of fiduciary duty.

Closing the Deal

While a down-round financing is not the ideal outcome for any company, obtaining funding to continue operations is generally better than the alternative of slashing or ceasing operations entirely. In a down economy, not all companies will be able to obtain funding, and receiving funding at a lower valuation than previous rounds is not necessarily indicative of the future value of a company. For a company looking to obtain funding through a down-round financing, we recommend the following steps be taken in order to minimize any potential liability to the company and its board of directors:

  • Appoint a special committee of disinterested board members to review, negotiate and approve the transaction;

  • Do not wait until the need for additional funds is dire. Rather, start looking for funding sources early, undertake a search for options outside of a down-round financing led by existing investors and carefully document those efforts;

  • Find an outside third-party investor to lead the round, but be mindful of the broad interpretation of conflicts of interest when determining if such outside third party is truly independent;

  • Engage in a rights offering whereby current investors are afforded the opportunity to participate in the current financing;

  • When feasible, obtain a third-party valuation or fairness opinion immediately prior the financing to show that the valuation utilized for the financing is reasonable and fair;

  • Disclose the terms of the financing to the stockholders as well as any potential conflicts of interest and obtain the approval of a majority of the disinterested stockholders;

  • Carefully document the deliberations of the special committee and the board with respect to valuation of the proposed transaction; and

  • Require or strongly encourage participating investors to seek their own counsel with respect to likelihood and scope of potential liability.

While following the recommendations discussed above can help minimize the risk of costly litigation and potential liability for breach of fiduciary duty, it is recommended that any company contemplating engaging in a down-round financing seek advice from experienced legal counsel prior to undertaking the process.

Jeremy Glaser

I love to represent growing ventures, particularly technology-based companies in software, mobile applications, biotechnology, medical devices, and clean energy. For more than 30 years I’ve helped companies raise angel and venture financing and achieve successful liquidity events, such as IPOs and sales. Having served as Executive Vice President of Mergers and Acquisitions for a venture-backed B2B software company that raised over $100 million — and as general counsel for an investment management company that managed billions of dollars — I also know first-hand what it’s like to be inside a growing business. When you work with me you get an experienced partner who knows the entire ecosystem — the law, tech and life science industries, the innovation community, the investment management business, and venture capital firms and other investors. I bring all of that experience together to help clients of every size achieve success. 

https://orb-flatworm-3nw8.squarespace.com/meet-the-team/jeremy-glaser
Previous
Previous

Part Seven of the COVID-19 Roadmap Series: Employee Physical and Mental Well-being During the COVID-19 Pandemic

Next
Next

Part Six of the COVID-19 Roadmap Series: Reporting to Work